Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Targeting Transcription Factors for Cancer Treatment

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Targeting Transcription Factors for Cancer Treatment

BearDownAZ

Jun 22, 2018 10:59AM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Targeting Transcription Factors for Cancer Treatment

in response to

Targeting Transcription Factors for Cancer Treatment

BearDownAZ

posted on Jun 27, 2018 12:03AM

Bear maybe you should be writing the article highlighting your favourite. Of course all under full disclosure.